447 related articles for article (PubMed ID: 25315204)
21. Improved glucose metabolism after gastric bypass: evolution of the paradigm.
Pournaras DJ; Nygren J; Hagström-Toft E; Arner P; le Roux CW; Thorell A
Surg Obes Relat Dis; 2016; 12(8):1457-1465. PubMed ID: 27387696
[TBL] [Abstract][Full Text] [Related]
22. Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study.
Nosso G; Griffo E; Cotugno M; Saldalamacchia G; Lupoli R; Pacini G; Riccardi G; Angrisani L; Capaldo B
Horm Metab Res; 2016 May; 48(5):312-7. PubMed ID: 26788926
[TBL] [Abstract][Full Text] [Related]
23. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
[TBL] [Abstract][Full Text] [Related]
24. Whey protein supplementation does not alter plasma branched-chained amino acid profiles but results in unique metabolomics patterns in obese women enrolled in an 8-week weight loss trial.
Piccolo BD; Comerford KB; Karakas SE; Knotts TA; Fiehn O; Adams SH
J Nutr; 2015 Apr; 145(4):691-700. PubMed ID: 25833773
[TBL] [Abstract][Full Text] [Related]
25. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
[TBL] [Abstract][Full Text] [Related]
26. Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.
Zhang XJ; Xiao Z; Yu HL; Zhang XX; Cheng Z; Tian HM
Arch Med Res; 2013 Aug; 44(6):437-43. PubMed ID: 23973197
[TBL] [Abstract][Full Text] [Related]
27. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
[TBL] [Abstract][Full Text] [Related]
28. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
29. Branched-chain amino acid catabolism rather than amino acids plasma concentrations is associated with diet-induced changes in insulin resistance in overweight to obese individuals.
Haufe S; Engeli S; Kaminski J; Witt H; Rein D; Kamlage B; Utz W; Fuhrmann JC; Haas V; Mähler A; Schulz-Menger J; Luft FC; Boschmann M; Jordan J
Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):858-864. PubMed ID: 28958691
[TBL] [Abstract][Full Text] [Related]
30. Metabolite signature of diabetes remission in individuals with obesity undergoing weight loss interventions.
Thaker VV; Kwee LC; Chen H; Bahnson J; Ilkayeva O; Muehlbauer MJ; Wolfe B; Purnell JQ; Pi-Sunyer X; Newgard CB; Shah SH; Laferrère B;
Obesity (Silver Spring); 2024 Feb; 32(2):304-314. PubMed ID: 37962326
[TBL] [Abstract][Full Text] [Related]
31. Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Rotellar F; Valentí V; Silva C; Gil MJ; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2011 Jan; 96(1):200-9. PubMed ID: 20943784
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Short- and Mid-term Efficacy and the Mechanisms of Gastric Bypass Surgeries on Managing Obese and Nonobese Type 2 Diabetes Mellitus: A Prospective Study.
Zhang X; Cheng Z; Xiao Z; Du X; Du J; Li Y; Long Y; Yu H; Zhang X; Tian H
Arch Med Res; 2015 May; 46(4):303-9. PubMed ID: 26087171
[TBL] [Abstract][Full Text] [Related]
33. Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect.
Holter MM; Dutia R; Stano SM; Prigeon RL; Homel P; McGinty JJ; Belsley SJ; Ren CJ; Rosen D; Laferrère B
Diabetes Care; 2017 Jan; 40(1):7-15. PubMed ID: 27999001
[TBL] [Abstract][Full Text] [Related]
34. Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery.
Shantavasinkul PC; Omotosho P; Corsino L; Portenier D; Torquati A
Surg Obes Relat Dis; 2016 Nov; 12(9):1640-1645. PubMed ID: 27989521
[TBL] [Abstract][Full Text] [Related]
35. Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes.
Steven S; Hollingsworth KG; Small PK; Woodcock SA; Pucci A; Aribasala B; Al-Mrabeh A; Batterham RL; Taylor R
Diabet Med; 2016 Dec; 33(12):1723-1731. PubMed ID: 27589584
[TBL] [Abstract][Full Text] [Related]
36. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
[TBL] [Abstract][Full Text] [Related]
37. Roux-en-Y Gastric Bypass Improves Hepatic Glucose Metabolism Involving Down-Regulation of Protein Tyrosine Phosphatase 1B in Obese Rats.
Mu S; Liu J; Guo W; Zhang S; Xiao X; Wang Z; Zhang J
Obes Facts; 2017; 10(3):191-206. PubMed ID: 28564652
[TBL] [Abstract][Full Text] [Related]
38. The effects of diet- and RYGB-induced weight loss on insulin sensitivity in obese patients with and without type 2 diabetes.
Hansen M; Lund MT; Jørgensen AL; Palsøe MK; van Hall G; Helge JW; Dela F
Acta Diabetol; 2016 Jun; 53(3):423-32. PubMed ID: 26496769
[TBL] [Abstract][Full Text] [Related]
39. Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.
Yan Y; Zhou Z; Kong F; Feng S; Li X; Sha Y; Zhang G; Liu H; Zhang H; Wang S; Hu C; Zhang X
Obes Surg; 2016 Nov; 26(11):2683-2690. PubMed ID: 27038047
[TBL] [Abstract][Full Text] [Related]
40. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.
Reed MA; Pories WJ; Chapman W; Pender J; Bowden R; Barakat H; Gavin TP; Green T; Tapscott E; Zheng D; Shankley N; Yieh L; Polidori D; Piccoli SP; Brenner-Gati L; Dohm GL
J Clin Endocrinol Metab; 2011 Aug; 96(8):2525-31. PubMed ID: 21593117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
